Literature DB >> 17590300

Which factors determine febrile seizure recurrence? A prospective study.

Efterpi Pavlidou1, Maria Tzitiridou, Eleftherios Kontopoulos, Christos P Panteliadis.   

Abstract

PURPOSE: Many factors have been studied as potential predictors of recurrent febrile seizures (FS), however the available data in literature are inconsistent. The aim of the present paper is to determine which factors are responsible for the first and for multiple recurrences of FS, in a large sample of children with a long-term follow up.
METHODS: Two hundred and sixty children were followed after their first FS. The inclusion criteria were: a history of a first febrile seizure; no personal history of afebrile seizures; no previous anticonvulsant medication and age between three months and six years. The median time of follow up was 4.3 years. We had a contact with the families of the children every 4-6 months and also in every recurrence.
RESULTS: Very significant prognostic markers for the first FS recurrence were low age at onset, recurrence within the same illness, frequent febrile episodes and maternal preponderance. Powerful prognostic factors that may predispose children who already have one recurrence to a second or more are low age at onset and especially positive family history of FS. Additionally, low temperature prior to the initial seizure is a powerful predictor for three or more recurrences.
CONCLUSIONS: Prognostic factors for FS recurrence are a useful tool for the clinician. It is obvious that as many powerful predictors a child has, the greater will be the risk for FS recurrence.

Entities:  

Mesh:

Year:  2007        PMID: 17590300     DOI: 10.1016/j.braindev.2007.05.001

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  14 in total

1.  Febrile seizures: a cloudy issue.

Authors:  Efterpi Pavlidou; Christos Panteliadis
Journal:  Eur J Pediatr       Date:  2009-07-04       Impact factor: 3.183

2. 

Authors:  Nicholas Monfries; Ran D Goldman
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

3.  Prophylactic antipyretics for prevention of febrile seizures following vaccination.

Authors:  Nicholas Monfries; Ran D Goldman
Journal:  Can Fam Physician       Date:  2017-02       Impact factor: 3.275

Review 4.  Use of antipyretics for preventing febrile seizure recurrence in children: a systematic review and meta-analysis.

Authors:  Risa Hashimoto; Maiko Suto; Mariko Tsuji; Hatoko Sasaki; Kenji Takehara; Akira Ishiguro; Masaya Kubota
Journal:  Eur J Pediatr       Date:  2020-10-30       Impact factor: 3.183

5.  Intermittent oral levetiracetam reduced recurrence of febrile seizure accompanied with epileptiform discharge: a pilot study.

Authors:  Lin-Yan Hu; Xiu-Yu Shi; Hui Li; Meng-Na Zhang; Shu-Fang Ma; Li-Ping Zou
Journal:  Ital J Pediatr       Date:  2018-06-15       Impact factor: 2.638

6.  Predictors of prognosis in patients with temporal lobe epilepsy after anterior temporal lobectomy.

Authors:  Zhenxing Sun; Huancong Zuo; Dan Yuan; Yaxing Sun; Kai Zhang; Zhiqiang Cui; Jin Wang
Journal:  Exp Ther Med       Date:  2015-09-18       Impact factor: 2.447

Review 7.  Actual insights into the clinical management of febrile seizures.

Authors:  Mario Mastrangelo; Fabio Midulla; Corrado Moretti
Journal:  Eur J Pediatr       Date:  2014-01-30       Impact factor: 3.183

Review 8.  Febrile seizures: recent developments and unanswered questions.

Authors:  Efterpi Pavlidou; Christian Hagel; Christos Panteliadis
Journal:  Childs Nerv Syst       Date:  2013-07-12       Impact factor: 1.475

9.  Febrile seizures: an epidemiological and outcome study of 482 cases.

Authors:  Lamia Sfaihi; Ines Maaloul; Sana Kmiha; Hajer Aloulou; Imen Chabchoub; Thouraya Kamoun; Mongia Hachicha
Journal:  Childs Nerv Syst       Date:  2012-05-09       Impact factor: 1.475

10.  Comment on childhood febrile seizures: overview and implications by Tonia Jones and Steven J. Jacobsen.

Authors:  Efterpi Pavlidou; Christos P Panteliadis
Journal:  Int J Med Sci       Date:  2007-10-15       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.